CVS 分拆不解决其根本问题
Opinion: STAT+: CVS’ split doesn’t fix its fundamental problem
CVS 健康是美国最大的医疗保健公司之一,其年收入超过 400 亿美元。近期宣布分拆为两个实体,但媒体将其视为对监管压力的回应,文章认为这并不能解决其根本问题。
PBMs are still benefiting off the backs of average Americans
By A.J. Loiacono
Nov. 9, 2026
Loiacono is CEO of Judi Health.
CVS Health is one of the largest companies in the U.S. It serves the health care needs of hundreds of millions of Americans annually, has a hand in nearly every part of the drug supply chain, and has more than $400 billion in annual revenue.
So when it announced last Wednesday that it will split into two entities, the news made waves.
Here’s the thing: Much of the media coverage frames this move as CVS unwinding its vertical integration in response to ongoing regulatory pressure. That is not what is happening here.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
A.J. Loiacono
来源:STAT 主站 · statnews.com